Christmas in China brings glittering decor and foreign influence concerns

By Ryan Woo BEIJING (Reuters) -Giant Christmas trees adorned with lights, tinsel and gift boxes greet shoppers at glittering malls in big Chinese cities like Shanghai and Chongqing, but in many parts of China, extending season’s greetings is out of the question. In southwest Yunnan province, a property management company issued a notice to shopping…

Read More

Chipmaker Nvidia raises $15 million for non-profits helping Israel-Hamas war-hit civilians

By Steven Scheer JERUSALEM (Reuters) – U.S. chipmaker Nvidia and its employees have donated $15 million to Israeli and foreign non-profit organisations that are supporting civilians affected by Israel’s war with Palestinian militant group Hamas. Thousands of employees from more than 30 countries donated a total of $5 million, which the company matched and doubled…

Read More

Pentagon says Iranian drone ‘attack’ hit chemical tanker near India

(Reuters) – A drone launched from Iran struck a chemical tanker in the Indian ocean early on Saturday, the U.S. Department of Defense said. “The motor vessel CHEM PLUTO, a Liberia-flagged, Japanese-owned, and Netherlands-operated chemical tanker was struck at approximately 10 a.m. local time (6 a.m. GMT) today in the Indian Ocean, 200 nautical miles…

Read More

Putin clears Rosbank’s purchase of Societe Generale’s Russian assets

MOSCOW (Reuters) -Russian President Vladimir Putin on Sunday signed a decree clearing the way for Rosbank to purchase stakes in leading Russian companies owned by Societe Generale. The decree said that Rosbank will be able to buy SocGen’s stakes in energy producers such as Rosneft and Gazprom, metals companies including Norilsk Nickel and Severstal, and…

Read More

Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 billion

By Michael Erman and Manas Mishra (Reuters) -Bristol Myers Squibb on Friday agreed to buy Karuna Therapeutics for $14 billion, gaining a promising new type of antipsychotic medicine to help power growth as patents on its older therapies expire later this decade. Karuna’s experimental schizophrenia drug, called KarXT, should drive sales through the late 2020s…

Read More